Showing 1 - 10 of 41
trials (RCT) were performed, all relevant health economics literature were identified ad analysed. Results: Clinical efficacy … confirmed. We found no significant differences in efficacy and safety of different biological treatments. Health economics … income countries. There is a lack of health economics results in Central-Eastern European countries however these data are …
Persistent link: https://www.econbiz.de/10010353085
Persistent link: https://www.econbiz.de/10010434928
OBJECTIVES: To compare the efficacy and safety of infliximab-biosimilar with other biological drugs for the treatment of active ankylosing spondylitis (AS). METHODS: Systematic literature review for randomized controlled trials (RCTs) with adalimumab, etanercept, golimumab, infliximab and...
Persistent link: https://www.econbiz.de/10010434939
OBJECTIVE: The aim of this meta-analysis was to compare the efficacy and safety of infliximab-biosimilar and other available biologicals for the treatment of rheumatoid arthritis (RA), namely abatacept, adalimumab, certolizumab pegol, etanercept, golimumab, infliximab, rituximab and tocilizumab....
Persistent link: https://www.econbiz.de/10010434940
This article studies the determinants of pharmaceutical innovation diffusion among specialists. To this end, it investigates the influences of six categories of factors—social embeddedness, socio-demography, scientific orientation, prescribing patterns, practice characteristics, and patient...
Persistent link: https://www.econbiz.de/10010435069
) and specialists (SPs) affects either the health status of patients or their pharmacy costs. To this end, it measures the … health status by the number of comorbidities diagnosed and treated. In strong GP–SP relationships, the patient health status … article finds that stronger ties result in lower pharmacy costs, but not in higher patient health statuses. Key points for …
Persistent link: https://www.econbiz.de/10011287951
crisis on health and health care. However, there is limited knowledge on this topic regarding the Central and Eastern … European (CEE) countries. The main aims of this study are to examine the effect of the financial crisis on health care spending … paper we also revised the literature for economic crisis related impact on health and health care system in these countries …
Persistent link: https://www.econbiz.de/10011287964
A szerzők célja azon tényezők azonosítása, amelyek szignifikánsan befolyásolják új, innovatívnak számító készítmények terjedési folyamatát. A gyógyszercégek számára a terjedési folyamat ismerete a marketing-költségvetés célirányos elköltése miatt fontos. Ezen túl,...
Persistent link: https://www.econbiz.de/10011287980
crisis on health and health care. However, there is limited knowledge on this topic regarding the Central and Eastern … European (CEE) countries. The main aims of this study are to examine the effect of the financial crisis on health care spending … paper we also revised the literature for economic crisis related impact on health and health care system in these countries …
Persistent link: https://www.econbiz.de/10011287993
Tanulmányunkban azt vizsgáljuk, hogy az orvosok közötti kapcsolatok közül a földrajzi közelség szerinti, az egyetemi évfolyamtársi és a közös publikációkban realizálódó társszerzői kapcsolatoknak van-e statisztikailag kimutatható hatásuk az új készítmények terjedési...
Persistent link: https://www.econbiz.de/10011319127